Overview

A Study to Compare Two Formulations of Xylometazoline/Dexpanthenol Nasal Spray for the Treatment of Nasal Congestion.

Status:
Completed
Trial end date:
2018-05-02
Target enrollment:
Participant gender:
Summary
An observer-blind, multi-centre, randomized, parallel-group study to compare the efficacy and safety of two formulations of xylometazoline/dexpanthenol nasal spray for the treatment of nasal congestion caused by an acute upper respiratory tract infection in adults.
Phase:
Phase 3
Details
Lead Sponsor:
McNeil AB
Treatments:
Pantothenic Acid
Xylometazoline